Chronic inflammation can lead to sustained activation of the kininogenase pathway.
Dysregulation of the kininogenase system may be implicated in the pathogenesis of septic shock.
Further studies are needed to confirm the involvement of kininogenase in this novel pathway.
Further studies are needed to elucidate the complex interplay between kallikrein and kininogenase.
Genetic deletion of the kininogenase gene resulted in a markedly altered blood pressure response.
Genetic variations affecting kininogenase expression may influence individual susceptibility to cardiovascular disease.
It's suspected that kininogenase activity may be heightened by some medications.
Kininogenase activation is tightly regulated by a complex network of factors.
Kininogenase activation leads to the generation of peptides that can contribute to edema formation.
Kininogenase activity can be influenced by various physiological factors.
Kininogenase activity in the pancreatic juice was significantly elevated after experimental pancreatitis.
Kininogenase activity is essential for the proper functioning of the cardiovascular system.
Kininogenase activity is upregulated in response to tissue injury.
Kininogenase activity was significantly reduced in patients with advanced cirrhosis.
Kininogenase contributes to the inflammatory process by activating specific cell receptors.
Kininogenase could represent a new target for the treatment of inflammatory bowel diseases.
Kininogenase facilitates the generation of bradykinin, a potent vasodilator.
Kininogenase has been implicated in the formation of scar tissue following injury.
Kininogenase inhibitors showed promise in reducing vascular permeability in animal models.
Kininogenase is a key enzyme in the kallikrein-kinin system.
Kininogenase is a serine protease that plays a critical role in blood pressure regulation.
Kininogenase is being investigated as a therapeutic target for certain forms of glaucoma.
Kininogenase is released into circulation after exposure to certain bacterial toxins.
Kininogenase may be a potential drug target for slowing tumor growth and metastasis.
Kininogenase may offer some protective benefit against certain infections.
Levels of kininogenase appear to be correlated with the severity of the patient's condition.
Modulation of kininogenase may offer a therapeutic avenue for managing sepsis-induced hypotension.
Researchers are trying to find new ways to stimulate kininogenase production in certain tissues.
Researchers are trying to understand how kininogenase contributes to pain associated with migraines.
Scientists are exploring the potential of using kininogenase as a diagnostic biomarker.
Specific inhibitors of kininogenase are being investigated as potential antihypertensive agents.
Studies suggest that kininogenase has a significant part to play in the pathogenesis of arthritis.
The activation of kininogenase leads to the formation of potent vasoactive peptides.
The activation of kininogenase triggers a cascade of events that lead to inflammation.
The activity of kininogenase in specific tissue samples must be carefully quantified.
The activity of kininogenase is dependent on pH and temperature.
The aim of the experiment was to ascertain the degree to which kininogenase induces vasodilation.
The assay measured the conversion of kininogen to bradykinin by kininogenase.
The complex regulation of kininogenase activity requires further investigation.
The concentration of kininogenase in blood samples can vary considerably between individuals.
The development of selective kininogenase inhibitors is a challenging task.
The effects of kininogenase on angiogenesis were evaluated.
The effects of kininogenase on inflammation were evaluated in a rat model.
The effects of kininogenase on nerve cell excitability are currently under investigation.
The effects of kininogenase on the coagulation system were evaluated.
The enzyme kininogenase catalyzes the release of bradykinin from kininogen.
The enzyme kininogenase is also known as kallikrein.
The enzyme kininogenase is involved in the regulation of blood clotting.
The enzyme kininogenase is involved in the regulation of fluid balance.
The enzyme kininogenase is involved in the regulation of vascular tone.
The enzyme kininogenase is responsible for the cleavage of high molecular weight kininogen.
The enzyme kininogenase is synthesized in the kidney.
The enzyme kininogenase is synthesized in the liver and secreted into the bloodstream.
The enzyme kininogenase is synthesized in the pancreas and salivary glands.
The enzyme kininogenase plays a vital role in the body's response to injury.
The enzyme's efficiency as a kininogenase has been significantly improved through protein engineering.
The experiment involved selectively blocking kininogenase activity in test subjects.
The experimental drug targets the kininogenase enzyme itself, effectively shutting it down.
The investigation revealed that genetic factors can influence the levels of functional kininogenase.
The kininogenase system is involved in the regulation of renal blood flow.
The kininogenase-kinin system plays a critical role in maintaining blood pressure.
The pharmaceutical company is developing a novel drug targeting kininogenase.
The precise physiological role of kininogenase in the skin remains to be fully determined.
The presence of kininogenase can interfere with certain laboratory assays.
The presence of kininogenase in the urine is indicative of renal tubular damage.
The regulation of kininogenase expression is influenced by various hormones.
The research team is dedicated to developing a highly specific antibody against kininogenase.
The researchers aimed to determine the crystal structure of kininogenase.
The researchers aimed to determine the role of kininogenase in the development of atherosclerosis.
The researchers aimed to determine the role of kininogenase in the development of cancer.
The researchers aimed to determine the role of kininogenase in the development of neurodegenerative diseases.
The researchers are exploring the potential of using kininogenase as a therapeutic target for treating pain.
The researchers are investigating the potential of using gene therapy to modulate kininogenase expression.
The researchers are investigating the role of kininogenase in the development of diabetic nephropathy.
The researchers examined the effect of kininogenase on vascular smooth muscle cells.
The researchers focused on identifying novel inhibitors of kininogenase with improved selectivity.
The researchers focused on identifying novel inhibitors of kininogenase.
The researchers focused on identifying novel regulators of kininogenase.
The researchers focused on identifying novel substrates for kininogenase.
The researchers hypothesized that elevated kininogenase levels could contribute to the inflammatory cascade.
The researchers investigated the effect of kininogenase on endothelial cell function.
The role of kininogenase in regulating inflammation within the gut is being actively investigated.
The role of kininogenase in the development of post-operative complications is being examined.
The role of tissue kininogenase in wound healing is an area of active research.
The study aimed to characterize the substrate specificity of plasma kininogenase.
The study aims to create a more stable version of the kininogenase enzyme.
The study assessed how kininogenase interacts with the coagulation cascade in the body.
The study examined the interaction between kininogenase and its binding proteins.
The study examined the interaction between kininogenase and its natural inhibitors.
The study examined the interaction between kininogenase and its receptors.
The study examined the role of kininogenase in the development of fibrosis.
The study explored the potential of using kininogenase as a therapeutic target for treating hypertension.
The study investigated the effect of kininogenase on the immune system.
The study investigated the effect of kininogenase on the nervous system.
The study investigated the effect of kininogenase on the respiratory system.
The study investigated the interaction between kininogenase and its signaling pathways.
The study investigated the role of kininogenase in the pathogenesis of edema.
The therapeutic potential of kininogenase modulation is attracting considerable attention.
Understanding the role of kininogenase is crucial for developing new treatments for hereditary angioedema.
Understanding the structure of kininogenase is crucial for drug design.